Institute of Biomedicine and Biotechnology (IBB), which was established in 2013, is oriented by clinical translation demand and industrial applications, and aims for the innovative solution to major diseases. The institute aims at seeking breakthroughs in core and cutting-edge technologies and innovative drugs development, creating first-class talents echelon formation, and deepening the regional biomedicine economy and clinical applications and benefiting people's health. In the coming future, the mission of IBB is to build a first-class scientists’ studios and R&D team for biomedicine and biotechnology, and to develop international cooperation, therefore promoting the integration of production, teaching and research.